Summarizing, the following conclusion may be drawn from the literature data and results presented here: overexpression of anti-apoptotic BCL2 family genes and underexpression of pro-apoptotic genes may facilitate and accelerate tumor development, and support tumor cell viability, but it is rather not the main driver of oncogenesis [109]. The gene discussed is BCL2; the disease is neoplasm.